Larger Clinical Trial for Alzheimer’s Drug Donanemab Starting Soon
Eli Lilly’s clinical trial of the experimental drug donanemab appears to have successfully slowed cognitive decline in patients with the early symptoms of Alzheimer’s. The TRAILBLAZER-ALZ clinical trial was a …
Larger Clinical Trial for Alzheimer’s Drug Donanemab Starting Soon Read More »